Showing results (11-20 of 76) with videos related to
Sort By:
Pageof 8
Annals of the New York Academy of Sciences|July 21, 2001
EEG biofeedback treatment of ADD. A viable alternative to traditional medical intervention?P M Ramirez, D Desantis, L A OplerHospital & Community Psychiatry|April 1, 1980
Tardive dyskinesia and institutional practice: current issues and guidelinesL A Opler, I Katz, J Kobayashi, et al.Psychological Medicine|February 1, 1987
Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: implications for psychobiological subtypingM M Singh, S R Kay, L A OplerPsychiatric Developments|January 1, 1988
The possible role of dopamine autoreceptors in neuroleptic atypicalityD C Javitt, S L Weinstein, L A OplerThe Psychiatric Clinics of North America|June 1, 1995
Pharmacologic treatment of delusionsL A Opler, D M Klahr, P M RamirezAnnals of the New York Academy of Sciences|July 21, 2001
Psychostimulants in the treatment of adults with psychosis and attention deficit disorderL A Opler, D M Frank, P M RamirezPsychiatry Research|January 1, 1988
Reliability and validity of the positive and negative syndrome scale for schizophrenicsS R Kay, L A Opler, J P LindenmayerJournal of Clinical Psychopharmacology|April 1, 1987
Amantadine in the treatment of neuroendocrine side effects of neurolepticsN Correa, L A Opler, S R Kay, et al.Acta Psychiatrica Scandinavica|November 1, 1986
Positive and negative syndromes in schizophrenia as a function of chronicityS R Kay, A Fiszbein, J P Lindenmayer, et al.Psychological Reports|April 1, 1994
Relationship between neuroleptic dose and positive and negative symptomsP B Johnson, P M Ramirez, L A Opler, et al.Pageof 8